Satsuma Pharmaceuticals (NASDAQ:STSA) Announces Quarterly Earnings Results

Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating) issued its quarterly earnings data on Tuesday. The financial services provider reported ($0.49) EPS for the quarter, meeting the consensus estimate of ($0.49), MarketWatch Earnings reports. Shares of NASDAQ:STSA traded down $0.01 during trading on Thursday, reaching $3.78. The stock had a trading volume of 34,273 shares, compared to […]

Related Keywords

,Geode Capital Management ,Satsuma Pharmaceuticals ,Earnings History For Satsuma Pharmaceuticals ,Zacks Investment Research ,Norges Bank ,Satsuma Pharmaceuticals Inc ,Susquehanna International Group ,Nasdaq ,Satsuma Pharmaceuticals Get Rating ,Citadel Advisors ,Get Rating ,Marketwatch Earnings ,International Group ,Street Corp ,Capital Management ,Nasdaq Stsa ,Stsa ,Medical ,85931930 ,Earnings ,